Tag: rfid in pharmaceuticals market forecast

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

How Is The Radio Frequency Identification (RFID) In Pharmaceuticals Market’s Market Value Anticipated To Evolve From 2026 To 2030?

The market for radio frequency identification (rfid) in pharmaceuticals has experienced rapid growth in recent years. Its value is projected to expand from $6.08 billion in 2025 to $6.74 billion in 2026, at a compound annual growth rate (CAGR) of 10.9%. The historical expansion of this market can be attributed to factors such as an increasing regulatory focus on drug traceability, a rise in counterfeit medicine incidents, the expansion of global pharmaceutical supply chains, the adoption of serialization mandates, and growing hospital inventory complexity.

The market for radio frequency identification (RFID) in the pharmaceutical sector is projected to experience substantial expansion over the coming years. This market is anticipated to reach a valuation of $10.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. This projected growth is driven by several factors including increased funding in digital pharmaceutical logistics, a heightened need for real-time insights into supply chains, the proliferation of RFID-equipped smart hospitals, wider acceptance of blockchain-integrated traceability solutions, and improved regulatory alignment across various regions. Key developments expected during this forecast period encompass the broader implementation of comprehensive drug track and trace systems, the increasing application of RFID for combating counterfeiting, stronger integration of RFID with serialization platforms, extended visibility into real-time pharmaceutical inventory, and a greater emphasis on the precision of cold chain monitoring.

Download A Free Sample Report For Comprehensive Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25891&type=smp

Which Growth Factors Are Strengthening The Radio Frequency Identification (RFID) In Pharmaceuticals Market Landscape?

The rising occurrences of fake medications are anticipated to drive the expansion of the radio frequency identification (RFID) in pharmaceuticals market in the future. Counterfeit drugs, also known as bogus medicines, are pharmaceutical products intentionally and deceitfully mislabeled concerning their identity or source. The surge in counterfeit drug incidents stems from the rapid proliferation of online pharmacies, which has made it easier for counterfeiters to disseminate fake drugs straight to consumers, thus circumventing established regulatory protections and complicating their detection. Radio frequency identification (RFID) in pharmaceuticals aids in combating counterfeit drugs by offering secure, traceable data that confirms product legitimacy throughout each phase of the supply chain. As an illustration, in December 2024, data from the American Chemical Society, a US-based nonprofit scientific society, indicated 6,987 counterfeit drug incidents were reported across 142 countries in 2023, marking a 4% rise from 2022. Consequently, the rising instances of counterfeit drugs are fueling the expansion of the radio frequency identification (RFID) in pharmaceuticals market.

What Segment Types Are Included In The Radio Frequency Identification (RFID) In Pharmaceuticals Market Analysis?

The radio frequency identification (rfid) in pharmaceuticals market covered in this report is segmented –

1) By Type: Chipped Radio Frequency Identification, Chipless Radio Frequency Identification

2) By Component: Radio Frequency Identification Tags, Radio Frequency Identification Readers, Middleware Software, Integration Services, Data Management Software

3) By Regulatory Compliance: Food And Drug Administration Compliance Standards, European Union Falsified Medicines Directive, Good Distribution Practices, Serialization Requirements, Tracking And Tracing Regulations

4) By Application: Drug Track And Trace System, Asset Tracking, Patient Safety, Other Applications

5) By End-User: Pharmaceutical Manufacturers, Hospitals And Healthcare Providers, Pharmacies And Drug Wholesalers, Research And Development Laboratories, Logistics And Supply Chain Companies

Subsegments:

1) By Chipped Radio Frequency Identification: Low Frequency Radio Frequency Identification, High Frequency Radio Frequency Identification, Ultra High Frequency Radio Frequency Identification, Active Radio Frequency Identification, Passive Radio Frequency Identification, Semi-Passive Radio Frequency Identification

2) By Chipless Radio Frequency Identification: Time Domain Reflectometry, Frequency Domain Reflectometry, Magnetic Resonance-Based Tags, Surface Acoustic Wave Tags, Printed Conductive Polymer Tags, Photonic Band Gap Structures

Which Trends Are Guiding The Development Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Major companies within the radiation toxicity treatment market are intensifying their efforts on technological advancements, particularly advanced drug delivery systems, to enhance the accuracy and efficacy of treatments, improve patient compliance, and reduce side effects. This ultimately aims to deliver superior therapeutic outcomes and accelerate recovery times. A drug delivery system is defined as a method for directing medication to specific areas of the body, thereby ensuring proper dosage and effectiveness while minimizing unwanted reactions. As an illustration, in December 2023, Coherus BioSciences, a US-based biopharmaceutical company, declared that the U.S. FDA had granted approval for UDENYCA ONBODY, which is a new on-body injector for pegfilgrastim-cbqv. This device is designed for application the day after chemotherapy to assist in lowering the risk of infection caused by febrile neutropenia. The injector delivers the medication swiftly in just five minutes and is equipped with a retractable needle for improved safety and comfort. Through this approval, Coherus seeks to offer a more convenient and user-friendly solution for managing the adverse effects of chemotherapy.

Who Are The Businesses Driving Activity In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Major companies operating in the radio frequency identification (rfid) in pharmaceuticals market are Fujitsu Limited, NXP Semiconductors NV, Avery Dennison Corporation, Zebra Technologies Corporation, CCL Industries Inc., HID Global Corporation, Checkpoint Systems Inc, Datalogic SpA, Impinj Inc, Schreiner Group GmbH & Co KG, Invengo Information Technology Co Ltd, GAO RFID Inc., Lowry Solutions Inc., Terso Solutions Inc., Xerafy Singapore Pte Ltd., Tageos SAS, SML Group Limited, Syrma SGS Technology Limited, Omnia Technologies Private Limited, identytag GmbH & Co KG

Access The Complete Radio Frequency Identification (RFID) In Pharmaceuticals Market Report:

https://www.thebusinessresearchcompany.com/report/radio-frequency-identification-rfid-in-pharmaceuticals-global-market-report

Which Region Holds The Largest Share In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

North America was the largest region in the radio frequency identification (RFID) in pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radio frequency identification (rfid) in pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Access Radio Frequency Identification (RFID) In Pharmaceuticals Market Report for Deeper Competitive Insights

https://www.thebusinessresearchcompany.com/customise?id=25891&type=smp

Browse Through More Reports Similar to the Global Radio Frequency Identification (RFID) In Pharmaceuticals Market 2026, By The Business Research Company

Medical Irradiation Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Radiotherapy Devices Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report

Single Dose Radiotherapy Services Global Market Report 2026

https://www.thebusinessresearchcompany.com/report/single-dose-radiotherapy-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas: +1 310-496-7795

Asia: +44 7882 955267 & +91 8897263534

Europe: +44 7882 955267

Email us at: marketing@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports feature enhanced tools like market attractiveness analysis, TAM assessment, and company scoring matrices, along with interactive dashboards, deeper supply chain insights, and startup coverage strengthening the depth, usability, and strategic value of insights.

What Is The Projected Increase In Market Value Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market During 2026–2030?

The radio frequency identification (rfid) in pharmaceuticals market size has seen rapid growth in recent years. It is projected to expand from $6.08 billion in 2025 to $6.74 billion in 2026, achieving a compound annual growth rate (CAGR) of 10.9%. The historical expansion can be attributed to a heightened regulatory focus on tracking drugs, an increase in incidents involving counterfeit medicines, the expansion of global pharmaceutical supply networks, the adoption of serialization mandates, and the growing intricacy of hospital inventories.

The market for radio frequency identification (rfid) in pharmaceuticals is projected to experience substantial expansion in the coming years. This market is anticipated to reach a valuation of $10.07 billion by 2030, showing a compound annual growth rate (CAGR) of 10.6%. This projected growth is driven by factors such as greater investments in digital pharmaceutical logistics, a heightened need for real-time supply chain transparency, the proliferation of rfid-equipped smart hospitals, the rising implementation of blockchain-integrated traceability solutions, and improved regulatory alignment across different areas. Key developments expected during this timeframe involve the wider uptake of comprehensive drug track and trace systems, increased deployment of rfid for combating counterfeit products, deeper integration of rfid with serialization platforms, extended real-time visibility into pharmaceutical inventory, and a stronger emphasis on precise cold chain monitoring.

Access Your Free Sample Report For In-Depth Market Analysis:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25891&type=smp

What Leading Drivers Are Supporting The Radio Frequency Identification (RFID) In Pharmaceuticals Market Expansion?

The rising occurrences of counterfeit drugs are anticipated to boost the growth of the radio frequency identification (RFID) in pharmaceuticals market moving forward. Counterfeit drugs, also known as fake medicines, are pharmaceutical items intentionally and fraudulently mislabeled regarding their origin or identity. The surge in counterfeit drug incidents is attributed to the rapid expansion of online pharmacies, which has simplified the distribution of fake medicines directly to consumers, circumventing traditional regulatory safeguards and hindering detection. Radio frequency identification (RFID) in pharmaceuticals assists in combating counterfeit drugs by providing secure, traceable data that verifies product authenticity at every phase of the supply chain. For example, in December 2024, the American Chemical Society, a US-based nonprofit scientific society, noted 6,987 reported counterfeit drug incidents across 142 countries in 2023, reflecting a 4% increase from 2022. Thus, the escalating incidence of counterfeit drugs is propelling the expansion of the radio frequency identification (RFID) in pharmaceuticals market.

How Is The Radio Frequency Identification (RFID) In Pharmaceuticals Market Organized By Segment Classification?

The radio frequency identification (rfid) in pharmaceuticals market covered in this report is segmented –

1) By Type: Chipped Radio Frequency Identification, Chipless Radio Frequency Identification

2) By Component: Radio Frequency Identification Tags, Radio Frequency Identification Readers, Middleware Software, Integration Services, Data Management Software

3) By Regulatory Compliance: Food And Drug Administration Compliance Standards, European Union Falsified Medicines Directive, Good Distribution Practices, Serialization Requirements, Tracking And Tracing Regulations

4) By Application: Drug Track And Trace System, Asset Tracking, Patient Safety, Other Applications

5) By End-User: Pharmaceutical Manufacturers, Hospitals And Healthcare Providers, Pharmacies And Drug Wholesalers, Research And Development Laboratories, Logistics And Supply Chain Companies

Subsegments:

1) By Chipped Radio Frequency Identification: Low Frequency Radio Frequency Identification, High Frequency Radio Frequency Identification, Ultra High Frequency Radio Frequency Identification, Active Radio Frequency Identification, Passive Radio Frequency Identification, Semi-Passive Radio Frequency Identification

2) By Chipless Radio Frequency Identification: Time Domain Reflectometry, Frequency Domain Reflectometry, Magnetic Resonance-Based Tags, Surface Acoustic Wave Tags, Printed Conductive Polymer Tags, Photonic Band Gap Structures

What Emerging Trends Are Seen In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Leading companies in the radio frequency identification (RFID) in pharmaceuticals market are concentrating on developing sophisticated RFID-enabled labels. This focus aims to boost product traceability, optimize inventory management, and combat the escalating threat of counterfeit drugs. RFID-enabled labels are intelligent tags that employ radio frequency technology to wirelessly identify, monitor, and authenticate pharmaceutical products throughout their entire supply chain. For instance, in May 2023, Fresenius Kabi AG, a Germany-based pharmaceutical company, launched its Rocuronium Bromide Injection with advanced RFID-enabled labeling, designed to enhance medication tracking, improve inventory control, and ensure patient safety in healthcare facilities. This injection is provided as a 50 mg per 5 mL multiple-dose vial for intravenous administration by trained medical professionals. The product incorporates advanced RFID-enabled smart labeling, which allows for real-time tracking, streamlines inventory processes, and helps minimize medication errors.

Who Are The Industry Participants Involved In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Major companies operating in the radio frequency identification (rfid) in pharmaceuticals market are Fujitsu Limited, NXP Semiconductors NV, Avery Dennison Corporation, Zebra Technologies Corporation, CCL Industries Inc., HID Global Corporation, Checkpoint Systems Inc, Datalogic SpA, Impinj Inc, Schreiner Group GmbH & Co KG, Invengo Information Technology Co Ltd, GAO RFID Inc., Lowry Solutions Inc., Terso Solutions Inc., Xerafy Singapore Pte Ltd., Tageos SAS, SML Group Limited, Syrma SGS Technology Limited, Omnia Technologies Private Limited, identytag GmbH & Co KG

Get The Full Radio Frequency Identification (RFID) In Pharmaceuticals Market Report:

https://www.thebusinessresearchcompany.com/report/radio-frequency-identification-rfid-in-pharmaceuticals-global-market-report

Which Region Represents The Largest Share Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

North America was the largest region in the radio frequency identification (RFID) in pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radio frequency identification (rfid) in pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Customized Radio Frequency Identification (RFID) In Pharmaceuticals Market Report For Competitive Insights:

https://www.thebusinessresearchcompany.com/report/radio-frequency-identification-rfid-in-pharmaceuticals-global-market-report

Browse Through More Reports Similar to the Global Radio Frequency Identification (RFID) In Pharmaceuticals Market 2026, By The Business Research Company

Medical Irradiation Market Report 2026

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Radiotherapy Devices Market Report

https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report

Single Dose Radiotherapy Services Market Report

https://www.thebusinessresearchcompany.com/report/single-dose-radiotherapy-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Radio Frequency Identification (RFID) In Pharmaceuticals Market By 2030 Starting From Its 2026 Size?

The market for radio frequency identification (RFID) in pharmaceuticals has experienced rapid expansion in recent years. This market is projected to expand from $6.08 billion in 2025 to $6.74 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.9%. Historically, this growth can be ascribed to several factors, including an increasing regulatory focus on drug traceability, a rise in incidents of counterfeit medicines, the expansion of global pharmaceutical supply chains, the adoption of serialization mandates, and the growing complexity of hospital inventory.

The radio frequency identification (rfid) in pharmaceuticals market is projected to experience substantial expansion in the coming years. It is anticipated to reach $10.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period is fueled by increasing investments in digital pharmaceutical logistics, a rising demand for real-time supply chain visibility, the expansion of rfid-enabled smart hospitals, growing adoption of blockchain-linked traceability systems, and increasing regulatory harmonization across regions. Significant trends expected during this period include the wider adoption of end-to-end drug track and trace systems, increased use of rfid for anti-counterfeiting measures, deeper integration of rfid with serialization platforms, expanded real-time pharmaceutical inventory visibility, and an enhanced focus on the accuracy of cold chain monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25891&type=smp

What Primary Drivers Are Shaping The Development Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

The rising occurrences of counterfeit drugs are projected to fuel the expansion of the radio frequency identification (RFID) in pharmaceuticals market in the future. Counterfeit drugs, sometimes referred to as fake medicines, are pharmaceutical items intentionally and deceitfully mislabeled concerning their identity or origin. The escalation in counterfeit drug cases stems from the quick rise of online pharmacies, which has facilitated counterfeiters in supplying fraudulent medications directly to consumers, circumventing established regulatory protections and complicating discovery. Radio frequency identification (RFID) in pharmaceuticals aids in combating fake drugs by offering secure, verifiable information that confirms product genuineness throughout the entire supply chain. For example, in December 2024, the American Chemical Society, a US-based nonprofit scientific society, reported 6,987 counterfeit drug incidents across 142 countries in 2023, marking a 4% rise from 2022. Consequently, the growing frequency of counterfeit drugs is stimulating the development of the radio frequency identification (RFID) in pharmaceuticals market.

Which Segment Categories Define The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

The radio frequency identification (rfid) in pharmaceuticals market covered in this report is segmented –

1) By Type: Chipped Radio Frequency Identification, Chipless Radio Frequency Identification

2) By Component: Radio Frequency Identification Tags, Radio Frequency Identification Readers, Middleware Software, Integration Services, Data Management Software

3) By Regulatory Compliance: Food And Drug Administration Compliance Standards, European Union Falsified Medicines Directive, Good Distribution Practices, Serialization Requirements, Tracking And Tracing Regulations

4) By Application: Drug Track And Trace System, Asset Tracking, Patient Safety, Other Applications

5) By End-User: Pharmaceutical Manufacturers, Hospitals And Healthcare Providers, Pharmacies And Drug Wholesalers, Research And Development Laboratories, Logistics And Supply Chain Companies

Subsegments:

1) By Chipped Radio Frequency Identification: Low Frequency Radio Frequency Identification, High Frequency Radio Frequency Identification, Ultra High Frequency Radio Frequency Identification, Active Radio Frequency Identification, Passive Radio Frequency Identification, Semi-Passive Radio Frequency Identification

2) By Chipless Radio Frequency Identification: Time Domain Reflectometry, Frequency Domain Reflectometry, Magnetic Resonance-Based Tags, Surface Acoustic Wave Tags, Printed Conductive Polymer Tags, Photonic Band Gap Structures

What Key Developments And Trends Are Impacting The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

In the radio frequency identification (RFID) in pharmaceuticals market, leading companies are dedicating efforts to creating sophisticated RFID-enabled labels. This initiative aims to improve product traceability, enhance inventory management, and counter the growing risk of counterfeit drugs. RFID-enabled labels are intelligent tags that leverage radio frequency technology to wirelessly identify, track, and authenticate pharmaceutical items throughout their supply chain. As an illustration, in May 2023, Fresenius Kabi AG, a pharmaceutical company based in Germany, launched its Rocuronium Bromide Injection, which incorporates advanced RFID-enabled labeling to boost medication tracking, inventory control, and patient safety within healthcare facilities. The injection is provided as a 50 mg per 5 mL multiple-dose vial intended for intravenous administration by qualified medical personnel. Its advanced RFID-enabled smart labeling facilitates real-time tracking, optimizes inventory procedures, and aids in minimizing medication errors.

Who Are The Top Companies Competing In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Major companies operating in the radio frequency identification (rfid) in pharmaceuticals market are Fujitsu Limited, NXP Semiconductors NV, Avery Dennison Corporation, Zebra Technologies Corporation, CCL Industries Inc., HID Global Corporation, Checkpoint Systems Inc, Datalogic SpA, Impinj Inc, Schreiner Group GmbH & Co KG, Invengo Information Technology Co Ltd, GAO RFID Inc., Lowry Solutions Inc., Terso Solutions Inc., Xerafy Singapore Pte Ltd., Tageos SAS, SML Group Limited, Syrma SGS Technology Limited, Omnia Technologies Private Limited, identytag GmbH & Co KG

Read the full radio frequency identification (rfid) in pharmaceuticals market report here:

https://www.thebusinessresearchcompany.com/report/radio-frequency-identification-rfid-in-pharmaceuticals-global-market-report

How Does The Radio Frequency Identification (RFID) In Pharmaceuticals Market Perform Across Major Global Regions?

North America was the largest region in the radio frequency identification (RFID) in pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radio frequency identification (rfid) in pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Radio Frequency Identification (RFID) In Pharmaceuticals Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25891&type=smp

Browse Through More Reports Similar to the Global Radio Frequency Identification (RFID) In Pharmaceuticals Market 2026, By The Business Research Company

Medical Irradiation Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Radiotherapy Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report

Single Dose Radiotherapy Services Global Market Report

https://www.thebusinessresearchcompany.com/report/single-dose-radiotherapy-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Radio Frequency Identification (RFID) In Pharmaceuticals Market By 2030 Starting From Its 2026 Size?

The market for radio frequency identification (RFID) in pharmaceuticals has experienced rapid expansion in recent years. This market is projected to expand from $6.08 billion in 2025 to $6.74 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.9%. Historically, this growth can be ascribed to several factors, including an increasing regulatory focus on drug traceability, a rise in incidents of counterfeit medicines, the expansion of global pharmaceutical supply chains, the adoption of serialization mandates, and the growing complexity of hospital inventory.

The radio frequency identification (rfid) in pharmaceuticals market is projected to experience substantial expansion in the coming years. It is anticipated to reach $10.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period is fueled by increasing investments in digital pharmaceutical logistics, a rising demand for real-time supply chain visibility, the expansion of rfid-enabled smart hospitals, growing adoption of blockchain-linked traceability systems, and increasing regulatory harmonization across regions. Significant trends expected during this period include the wider adoption of end-to-end drug track and trace systems, increased use of rfid for anti-counterfeiting measures, deeper integration of rfid with serialization platforms, expanded real-time pharmaceutical inventory visibility, and an enhanced focus on the accuracy of cold chain monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25891&type=smp

What Primary Drivers Are Shaping The Development Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

The rising occurrences of counterfeit drugs are projected to fuel the expansion of the radio frequency identification (RFID) in pharmaceuticals market in the future. Counterfeit drugs, sometimes referred to as fake medicines, are pharmaceutical items intentionally and deceitfully mislabeled concerning their identity or origin. The escalation in counterfeit drug cases stems from the quick rise of online pharmacies, which has facilitated counterfeiters in supplying fraudulent medications directly to consumers, circumventing established regulatory protections and complicating discovery. Radio frequency identification (RFID) in pharmaceuticals aids in combating fake drugs by offering secure, verifiable information that confirms product genuineness throughout the entire supply chain. For example, in December 2024, the American Chemical Society, a US-based nonprofit scientific society, reported 6,987 counterfeit drug incidents across 142 countries in 2023, marking a 4% rise from 2022. Consequently, the growing frequency of counterfeit drugs is stimulating the development of the radio frequency identification (RFID) in pharmaceuticals market.

Which Segment Categories Define The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

The radio frequency identification (rfid) in pharmaceuticals market covered in this report is segmented –

1) By Type: Chipped Radio Frequency Identification, Chipless Radio Frequency Identification

2) By Component: Radio Frequency Identification Tags, Radio Frequency Identification Readers, Middleware Software, Integration Services, Data Management Software

3) By Regulatory Compliance: Food And Drug Administration Compliance Standards, European Union Falsified Medicines Directive, Good Distribution Practices, Serialization Requirements, Tracking And Tracing Regulations

4) By Application: Drug Track And Trace System, Asset Tracking, Patient Safety, Other Applications

5) By End-User: Pharmaceutical Manufacturers, Hospitals And Healthcare Providers, Pharmacies And Drug Wholesalers, Research And Development Laboratories, Logistics And Supply Chain Companies

Subsegments:

1) By Chipped Radio Frequency Identification: Low Frequency Radio Frequency Identification, High Frequency Radio Frequency Identification, Ultra High Frequency Radio Frequency Identification, Active Radio Frequency Identification, Passive Radio Frequency Identification, Semi-Passive Radio Frequency Identification

2) By Chipless Radio Frequency Identification: Time Domain Reflectometry, Frequency Domain Reflectometry, Magnetic Resonance-Based Tags, Surface Acoustic Wave Tags, Printed Conductive Polymer Tags, Photonic Band Gap Structures

What Key Developments And Trends Are Impacting The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

In the radio frequency identification (RFID) in pharmaceuticals market, leading companies are dedicating efforts to creating sophisticated RFID-enabled labels. This initiative aims to improve product traceability, enhance inventory management, and counter the growing risk of counterfeit drugs. RFID-enabled labels are intelligent tags that leverage radio frequency technology to wirelessly identify, track, and authenticate pharmaceutical items throughout their supply chain. As an illustration, in May 2023, Fresenius Kabi AG, a pharmaceutical company based in Germany, launched its Rocuronium Bromide Injection, which incorporates advanced RFID-enabled labeling to boost medication tracking, inventory control, and patient safety within healthcare facilities. The injection is provided as a 50 mg per 5 mL multiple-dose vial intended for intravenous administration by qualified medical personnel. Its advanced RFID-enabled smart labeling facilitates real-time tracking, optimizes inventory procedures, and aids in minimizing medication errors.

Who Are The Top Companies Competing In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Major companies operating in the radio frequency identification (rfid) in pharmaceuticals market are Fujitsu Limited, NXP Semiconductors NV, Avery Dennison Corporation, Zebra Technologies Corporation, CCL Industries Inc., HID Global Corporation, Checkpoint Systems Inc, Datalogic SpA, Impinj Inc, Schreiner Group GmbH & Co KG, Invengo Information Technology Co Ltd, GAO RFID Inc., Lowry Solutions Inc., Terso Solutions Inc., Xerafy Singapore Pte Ltd., Tageos SAS, SML Group Limited, Syrma SGS Technology Limited, Omnia Technologies Private Limited, identytag GmbH & Co KG

Read the full radio frequency identification (rfid) in pharmaceuticals market report here:

https://www.thebusinessresearchcompany.com/report/radio-frequency-identification-rfid-in-pharmaceuticals-global-market-report

How Does The Radio Frequency Identification (RFID) In Pharmaceuticals Market Perform Across Major Global Regions?

North America was the largest region in the radio frequency identification (RFID) in pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radio frequency identification (rfid) in pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Radio Frequency Identification (RFID) In Pharmaceuticals Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25891&type=smp

Browse Through More Reports Similar to the Global Radio Frequency Identification (RFID) In Pharmaceuticals Market 2026, By The Business Research Company

Medical Irradiation Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Radiotherapy Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report

Single Dose Radiotherapy Services Global Market Report

https://www.thebusinessresearchcompany.com/report/single-dose-radiotherapy-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

What Market Valuation Is Forecasted For The Radio Frequency Identification (RFID) In Pharmaceuticals Market By 2030 Starting From Its 2026 Size?

The market for radio frequency identification (RFID) in pharmaceuticals has experienced rapid expansion in recent years. This market is projected to expand from $6.08 billion in 2025 to $6.74 billion in 2026, demonstrating a compound annual growth rate (CAGR) of 10.9%. Historically, this growth can be ascribed to several factors, including an increasing regulatory focus on drug traceability, a rise in incidents of counterfeit medicines, the expansion of global pharmaceutical supply chains, the adoption of serialization mandates, and the growing complexity of hospital inventory.

The radio frequency identification (rfid) in pharmaceuticals market is projected to experience substantial expansion in the coming years. It is anticipated to reach $10.07 billion by 2030, demonstrating a compound annual growth rate (CAGR) of 10.6%. This growth during the forecast period is fueled by increasing investments in digital pharmaceutical logistics, a rising demand for real-time supply chain visibility, the expansion of rfid-enabled smart hospitals, growing adoption of blockchain-linked traceability systems, and increasing regulatory harmonization across regions. Significant trends expected during this period include the wider adoption of end-to-end drug track and trace systems, increased use of rfid for anti-counterfeiting measures, deeper integration of rfid with serialization platforms, expanded real-time pharmaceutical inventory visibility, and an enhanced focus on the accuracy of cold chain monitoring.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=25891&type=smp

What Primary Drivers Are Shaping The Development Of The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

The rising occurrences of counterfeit drugs are projected to fuel the expansion of the radio frequency identification (RFID) in pharmaceuticals market in the future. Counterfeit drugs, sometimes referred to as fake medicines, are pharmaceutical items intentionally and deceitfully mislabeled concerning their identity or origin. The escalation in counterfeit drug cases stems from the quick rise of online pharmacies, which has facilitated counterfeiters in supplying fraudulent medications directly to consumers, circumventing established regulatory protections and complicating discovery. Radio frequency identification (RFID) in pharmaceuticals aids in combating fake drugs by offering secure, verifiable information that confirms product genuineness throughout the entire supply chain. For example, in December 2024, the American Chemical Society, a US-based nonprofit scientific society, reported 6,987 counterfeit drug incidents across 142 countries in 2023, marking a 4% rise from 2022. Consequently, the growing frequency of counterfeit drugs is stimulating the development of the radio frequency identification (RFID) in pharmaceuticals market.

Which Segment Categories Define The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

The radio frequency identification (rfid) in pharmaceuticals market covered in this report is segmented –

1) By Type: Chipped Radio Frequency Identification, Chipless Radio Frequency Identification

2) By Component: Radio Frequency Identification Tags, Radio Frequency Identification Readers, Middleware Software, Integration Services, Data Management Software

3) By Regulatory Compliance: Food And Drug Administration Compliance Standards, European Union Falsified Medicines Directive, Good Distribution Practices, Serialization Requirements, Tracking And Tracing Regulations

4) By Application: Drug Track And Trace System, Asset Tracking, Patient Safety, Other Applications

5) By End-User: Pharmaceutical Manufacturers, Hospitals And Healthcare Providers, Pharmacies And Drug Wholesalers, Research And Development Laboratories, Logistics And Supply Chain Companies

Subsegments:

1) By Chipped Radio Frequency Identification: Low Frequency Radio Frequency Identification, High Frequency Radio Frequency Identification, Ultra High Frequency Radio Frequency Identification, Active Radio Frequency Identification, Passive Radio Frequency Identification, Semi-Passive Radio Frequency Identification

2) By Chipless Radio Frequency Identification: Time Domain Reflectometry, Frequency Domain Reflectometry, Magnetic Resonance-Based Tags, Surface Acoustic Wave Tags, Printed Conductive Polymer Tags, Photonic Band Gap Structures

What Key Developments And Trends Are Impacting The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

In the radio frequency identification (RFID) in pharmaceuticals market, leading companies are dedicating efforts to creating sophisticated RFID-enabled labels. This initiative aims to improve product traceability, enhance inventory management, and counter the growing risk of counterfeit drugs. RFID-enabled labels are intelligent tags that leverage radio frequency technology to wirelessly identify, track, and authenticate pharmaceutical items throughout their supply chain. As an illustration, in May 2023, Fresenius Kabi AG, a pharmaceutical company based in Germany, launched its Rocuronium Bromide Injection, which incorporates advanced RFID-enabled labeling to boost medication tracking, inventory control, and patient safety within healthcare facilities. The injection is provided as a 50 mg per 5 mL multiple-dose vial intended for intravenous administration by qualified medical personnel. Its advanced RFID-enabled smart labeling facilitates real-time tracking, optimizes inventory procedures, and aids in minimizing medication errors.

Who Are The Top Companies Competing In The Radio Frequency Identification (RFID) In Pharmaceuticals Market?

Major companies operating in the radio frequency identification (rfid) in pharmaceuticals market are Fujitsu Limited, NXP Semiconductors NV, Avery Dennison Corporation, Zebra Technologies Corporation, CCL Industries Inc., HID Global Corporation, Checkpoint Systems Inc, Datalogic SpA, Impinj Inc, Schreiner Group GmbH & Co KG, Invengo Information Technology Co Ltd, GAO RFID Inc., Lowry Solutions Inc., Terso Solutions Inc., Xerafy Singapore Pte Ltd., Tageos SAS, SML Group Limited, Syrma SGS Technology Limited, Omnia Technologies Private Limited, identytag GmbH & Co KG

Read the full radio frequency identification (rfid) in pharmaceuticals market report here:

https://www.thebusinessresearchcompany.com/report/radio-frequency-identification-rfid-in-pharmaceuticals-global-market-report

How Does The Radio Frequency Identification (RFID) In Pharmaceuticals Market Perform Across Major Global Regions?

North America was the largest region in the radio frequency identification (RFID) in pharmaceuticals market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the radio frequency identification (rfid) in pharmaceuticals market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Radio Frequency Identification (RFID) In Pharmaceuticals Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=25891&type=smp

Browse Through More Reports Similar to the Global Radio Frequency Identification (RFID) In Pharmaceuticals Market 2026, By The Business Research Company

Medical Irradiation Global Market Report

https://www.thebusinessresearchcompany.com/report/medical-irradiation-global-market-report

Radiotherapy Devices Global Market Report

https://www.thebusinessresearchcompany.com/report/radiotherapy-devices-global-market-report

Single Dose Radiotherapy Services Global Market Report

https://www.thebusinessresearchcompany.com/report/single-dose-radiotherapy-services-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Asia +44 7882 955267 & +91 8897263534

Europe +44 7882 955267

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model